Logo image of UMAC

UNUSUAL MACHINES INC /US (UMAC) Stock Fundamental Analysis

USA - NYSEARCA:UMAC - US91532F1021 - Common Stock

14.35 USD
+0.98 (+7.33%)
Last: 10/13/2025, 3:35:32 PM
Fundamental Rating

4

Taking everything into account, UMAC scores 4 out of 10 in our fundamental rating. UMAC was compared to 124 industry peers in the Electronic Equipment, Instruments & Components industry. UMAC has a great financial health rating, but its profitability evaluates not so good. UMAC is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

UMAC had negative earnings in the past year.
In the past year UMAC has reported a negative cash flow from operations.
UMAC had negative earnings in each of the past 5 years.
In the past 5 years UMAC always reported negative operating cash flow.
UMAC Yearly Net Income VS EBIT VS OCF VS FCFUMAC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

UMAC has a Return On Assets of -75.30%. This is amonst the worse of the industry: UMAC underperforms 91.13% of its industry peers.
With a Return On Equity value of -76.97%, UMAC is not doing good in the industry: 79.03% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -75.3%
ROE -76.97%
ROIC N/A
ROA(3y)-130.57%
ROA(5y)-90.46%
ROE(3y)-141%
ROE(5y)-96.71%
ROIC(3y)N/A
ROIC(5y)N/A
UMAC Yearly ROA, ROE, ROICUMAC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 -50 -100 -150 -200

1.3 Margins

UMAC has a Gross Margin (29.15%) which is comparable to the rest of the industry.
UMAC's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for UMAC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-34.75%
GM growth 5YN/A
UMAC Yearly Profit, Operating, Gross MarginsUMAC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -1K -2K -3K

More info and screens

8

2. Health

2.1 Basic Checks

UMAC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for UMAC has been increased compared to 1 year ago.
There is no outstanding debt for UMAC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
UMAC Yearly Shares OutstandingUMAC Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M
UMAC Yearly Total Debt VS Total AssetsUMAC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

UMAC has an Altman-Z score of 217.00. This indicates that UMAC is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of UMAC (217.00) is better than 100.00% of its industry peers.
There is no outstanding debt for UMAC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 217
ROIC/WACCN/A
WACC9.09%
UMAC Yearly LT Debt VS Equity VS FCFUMAC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M 10M

2.3 Liquidity

UMAC has a Current Ratio of 51.38. This indicates that UMAC is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 51.38, UMAC belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
UMAC has a Quick Ratio of 49.43. This indicates that UMAC is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of UMAC (49.43) is better than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 51.38
Quick Ratio 49.43
UMAC Yearly Current Assets VS Current LiabilitesUMAC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2M 4M 6M

More info and screens

6

3. Growth

3.1 Past

UMAC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -717.95%.
Looking at the last year, UMAC shows a very strong growth in Revenue. The Revenue has grown by 279.39%.
The Revenue has been growing by 936.35% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-717.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-99.19%
Revenue 1Y (TTM)279.39%
Revenue growth 3Y936.35%
Revenue growth 5YN/A
Sales Q2Q%50.52%

3.2 Future

UMAC is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.89% yearly.
Based on estimates for the next years, UMAC will show a very strong growth in Revenue. The Revenue will grow by 89.94% on average per year.
EPS Next Y-38.19%
EPS Next 2Y18.68%
EPS Next 3Y17.89%
EPS Next 5YN/A
Revenue Next Year58.14%
Revenue Next 2Y86.08%
Revenue Next 3Y89.94%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
UMAC Yearly Revenue VS EstimatesUMAC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2024 2025 2026 2027 10M 20M 30M 40M
UMAC Yearly EPS VS EstimatesUMAC Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 -0.2 -0.4 -0.6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for UMAC. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for UMAC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
UMAC Price Earnings VS Forward Price EarningsUMAC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
UMAC Per share dataUMAC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2 -3

4.3 Compensation for Growth

A more expensive valuation may be justified as UMAC's earnings are expected to grow with 17.89% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y18.68%
EPS Next 3Y17.89%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for UMAC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

UNUSUAL MACHINES INC /US

NYSEARCA:UMAC (10/13/2025, 3:35:32 PM)

14.35

+0.98 (+7.33%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)08-14 2025-08-14/amc
Earnings (Next)N/A N/A
Inst Owners12.16%
Inst Owner Change0%
Ins Owners6.86%
Ins Owner Change9.51%
Market Cap444.42M
Analysts82.22
Price Target17.34 (20.84%)
Short Float %12.58%
Short Ratio1.24
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-194.93%
Min EPS beat(2)-318.3%
Max EPS beat(2)-71.57%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)17.04%
Min Revenue beat(2)14.93%
Max Revenue beat(2)19.14%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.56%
PT rev (3m)27.5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-18.46%
EPS NY rev (1m)-14.69%
EPS NY rev (3m)-62.37%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.71%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-28.35%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 57.7
P/FCF N/A
P/OCF N/A
P/B 8.66
P/tB 10.65
EV/EBITDA N/A
EPS(TTM)-3.52
EYN/A
EPS(NY)-0.28
Fwd EYN/A
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)-0.18
OCFYN/A
SpS0.25
BVpS1.66
TBVpS1.35
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -75.3%
ROE -76.97%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 29.15%
FCFM N/A
ROA(3y)-130.57%
ROA(5y)-90.46%
ROE(3y)-141%
ROE(5y)-96.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-34.75%
GM growth 5YN/A
F-Score4
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 51.38
Quick Ratio 49.43
Altman-Z 217
F-Score4
WACC9.09%
ROIC/WACCN/A
Cap/Depr(3y)189.42%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-717.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-99.19%
EPS Next Y-38.19%
EPS Next 2Y18.68%
EPS Next 3Y17.89%
EPS Next 5YN/A
Revenue 1Y (TTM)279.39%
Revenue growth 3Y936.35%
Revenue growth 5YN/A
Sales Q2Q%50.52%
Revenue Next Year58.14%
Revenue Next 2Y86.08%
Revenue Next 3Y89.94%
Revenue Next 5YN/A
EBIT growth 1Y-329.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-7.96%
EBIT Next 3Y35.96%
EBIT Next 5YN/A
FCF growth 1Y-190.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-178.19%
OCF growth 3YN/A
OCF growth 5YN/A